Then, variants in SDH genes lead to complex II dysfunction, elevated succinate levels, the inhibition of prolyl hydroxylase (which typically regulates HIFα, thereby leading to increased activity of HIFα), and the inhibition of DNA demethylases, leading to global tumor DNA hypermethylation [27]. This evidence concerns the gene SDHB and neoplasm.